Citadel Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.4M | Buy |
5,406,193
+5,063,889
| +1,479% | +$25.7M | 0.02% | 2036 |
|
|
2025
Q4 | $1.46M | Sell |
342,304
-1,458,131
| -81% | -$5.54M | ﹤0.01% | 6573 |
|
|
2025
Q3 | $5.74M | Buy |
1,800,435
+1,714,926
| +2,006% | +$3.86M | ﹤0.01% | 4111 |
|
|
2025
Q2 | $194K | Buy |
85,509
+85,409
| +85,409% | +$138K | ﹤0.01% | 10705 |
|
|
2025
Q1 | $64 | Sell |
100
-322,211
| -100% | -$250K | ﹤0.01% | 14344 |
|
|
2024
Q4 | $332K | Buy |
322,311
+5,192
| +2% | +$5.59K | ﹤0.01% | 9444 |
|
|
2024
Q3 | $374K | Sell |
317,119
-177,524
| -36% | -$225K | ﹤0.01% | 8850 |
|
|
2024
Q2 | $603K | Buy |
494,643
+457,866
| +1,245% | +$911K | ﹤0.01% | 7660 |
|
|
2024
Q1 | $80.2K | Sell |
36,777
-216,506
| -85% | -$400K | ﹤0.01% | 11654 |
|
|
2023
Q4 | $393K | Buy |
253,283
+193,117
| +321% | +$254K | ﹤0.01% | 8605 |
|
|
2023
Q3 | $77.6K | Buy |
60,166
+51,312
| +580% | +$80.8K | ﹤0.01% | 11208 |
|
|
2023
Q2 | $15.2K | Sell |
8,854
-269,823
| -97% | -$448K | ﹤0.01% | 12959 |
|
|
2023
Q1 | $421K | Sell |
278,677
-179,241
| -39% | -$405K | ﹤0.01% | 8659 |
|
|
2022
Q4 | $733K | Buy |
457,918
+408,759
| +832% | +$605K | ﹤0.01% | 7440 |
|
|
2022
Q3 | $71K | Sell |
49,159
-286,830
| -85% | -$441K | ﹤0.01% | 11367 |
|
|
2022
Q2 | $615K | Buy |
335,989
+321,607
| +2,236% | +$616K | ﹤0.01% | 8179 |
|
|
2022
Q1 | $38K | Sell |
14,382
-23,688
| -62% | -$91K | ﹤0.01% | 12966 |
|
|
2021
Q4 | $165K | Buy |
+38,070
| New | +$223K | ﹤0.01% | 12138 |
|
|
2021
Q3 | – | Sell |
-769,766
| Closed | -$4.12M | – | 13915 |
|
|
2021
Q2 | $4.87M | Sell |
769,766
-160,144
| -17% | -$1.25M | 0.01% | 4498 |
|
|
2021
Q1 | $7.19M | Buy |
929,910
+744,644
| +402% | +$5.89M | 0.01% | 3523 |
|
|
2020
Q4 | $1.21M | Sell |
185,266
-95,660
| -34% | -$683K | ﹤0.01% | 6388 |
|
|
2020
Q3 | $1.87M | Buy |
280,926
+212,861
| +313% | +$1.58M | ﹤0.01% | 4838 |
|
|
2020
Q2 | $567K | Sell |
68,065
-134,041
| -66% | -$1.24M | ﹤0.01% | 6852 |
|
|
2020
Q1 | $1.55M | Sell |
202,106
-233,463
| -54% | -$1.63M | ﹤0.01% | 4558 |
|
|
2019
Q4 | $3.62M | Buy |
435,569
+203,094
| +87% | +$1.37M | ﹤0.01% | 3530 |
|
|
2019
Q3 | $1.72M | Buy |
+232,475
| New | +$2.29M | ﹤0.01% | 4732 |
|
|
2019
Q2 | – | Sell |
-34,290
| Closed | -$368K | – | 9271 |
|
|
2019
Q1 | $368K | Buy |
+34,290
| New | +$507K | ﹤0.01% | 7300 |
|
|
2018
Q4 | – | Sell |
-27,081
| Closed | -$501K | – | 9223 |
|
|
2018
Q3 | $501K | Buy |
27,081
+4,602
| +20% | +$105K | ﹤0.01% | 6693 |
|
|
2018
Q2 | $514K | Sell |
22,479
-24,537
| -52% | -$627K | ﹤0.01% | 6320 |
|
|
2018
Q1 | $1.34M | Buy |
+47,016
| New | +$1.34M | ﹤0.01% | 4360 |
|
|
2017
Q3 | – | Sell |
-31,043
| Closed | -$481K | – | 7623 |
|
|
2017
Q2 | $481K | Buy |
31,043
+12,927
| +71% | +$195K | ﹤0.01% | 5170 |
|
|
2017
Q1 | $313K | Buy |
+18,116
| New | +$238K | ﹤0.01% | 5826 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
BBA